 Andrew McIntosh
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 27 | 2025 | 1407 | 1.890 |
Why?
| | Schizophrenia | 12 | 2022 | 453 | 1.390 |
Why?
| | Genetic Predisposition to Disease | 24 | 2025 | 2378 | 1.120 |
Why?
| | Antidepressive Agents | 3 | 2021 | 242 | 1.100 |
Why?
| | Bipolar Disorder | 7 | 2025 | 282 | 0.930 |
Why?
| | Mental Disorders | 9 | 2022 | 1163 | 0.810 |
Why?
| | Pregnancy Proteins | 1 | 2021 | 36 | 0.690 |
Why?
| | Scotland | 7 | 2022 | 30 | 0.690 |
Why?
| | Electronic Mail | 1 | 2020 | 60 | 0.610 |
Why?
| | Depression | 6 | 2024 | 1546 | 0.590 |
Why?
| | Pharmacoepidemiology | 1 | 2019 | 23 | 0.580 |
Why?
| | Polymorphism, Single Nucleotide | 16 | 2024 | 2158 | 0.560 |
Why?
| | Biological Specimen Banks | 6 | 2021 | 109 | 0.550 |
Why?
| | Drug Utilization | 1 | 2019 | 168 | 0.540 |
Why?
| | Health Surveys | 1 | 2020 | 518 | 0.540 |
Why?
| | Phenotype | 8 | 2025 | 3155 | 0.510 |
Why?
| | Cohort Studies | 13 | 2025 | 6013 | 0.470 |
Why?
| | Prescription Drugs | 1 | 2017 | 111 | 0.470 |
Why?
| | Synaptic Transmission | 1 | 2018 | 292 | 0.460 |
Why?
| | Drug Monitoring | 1 | 2019 | 401 | 0.440 |
Why?
| | Multifactorial Inheritance | 5 | 2021 | 195 | 0.440 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2015 | 66 | 0.440 |
Why?
| | Mood Disorders | 4 | 2021 | 143 | 0.440 |
Why?
| | United Kingdom | 7 | 2021 | 344 | 0.430 |
Why?
| | Genetic Loci | 5 | 2019 | 264 | 0.420 |
Why?
| | Psychotic Disorders | 4 | 2021 | 189 | 0.420 |
Why?
| | Magnetic Resonance Imaging | 8 | 2025 | 3904 | 0.420 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 591 | 0.410 |
Why?
| | Sex Characteristics | 5 | 2022 | 782 | 0.390 |
Why?
| | Mental Health | 1 | 2020 | 793 | 0.380 |
Why?
| | Brain Mapping | 3 | 2019 | 538 | 0.380 |
Why?
| | Calcium Channels | 1 | 2014 | 157 | 0.380 |
Why?
| | DNA Methylation | 4 | 2022 | 674 | 0.360 |
Why?
| | Epigenomics | 2 | 2023 | 114 | 0.350 |
Why?
| | Memory, Short-Term | 1 | 2014 | 268 | 0.340 |
Why?
| | Brain | 9 | 2025 | 2947 | 0.340 |
Why?
| | Temperament | 1 | 2011 | 40 | 0.330 |
Why?
| | Family Health | 1 | 2011 | 191 | 0.310 |
Why?
| | Genomics | 4 | 2025 | 825 | 0.310 |
Why?
| | Humans | 55 | 2025 | 145475 | 0.290 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1747 | 0.280 |
Why?
| | Neuroimaging | 4 | 2020 | 297 | 0.280 |
Why?
| | Aging | 7 | 2025 | 1969 | 0.280 |
Why?
| | Cognition | 3 | 2024 | 1266 | 0.250 |
Why?
| | Depressive Disorder | 2 | 2022 | 374 | 0.250 |
Why?
| | Off-Road Motor Vehicles | 1 | 2025 | 4 | 0.230 |
Why?
| | Accidents, Occupational | 1 | 2025 | 19 | 0.230 |
Why?
| | Agriculture | 1 | 2025 | 94 | 0.210 |
Why?
| | Substance-Related Disorders | 3 | 2021 | 1102 | 0.210 |
Why?
| | Female | 30 | 2025 | 78845 | 0.200 |
Why?
| | Male | 28 | 2025 | 72843 | 0.200 |
Why?
| | Linkage Disequilibrium | 3 | 2020 | 253 | 0.200 |
Why?
| | Adult | 23 | 2025 | 40777 | 0.200 |
Why?
| | Safety | 1 | 2025 | 358 | 0.190 |
Why?
| | Genetic Variation | 3 | 2018 | 972 | 0.190 |
Why?
| | Neuroticism | 2 | 2019 | 16 | 0.190 |
Why?
| | Quantitative Trait Loci | 3 | 2020 | 378 | 0.190 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2597 | 0.190 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2016 | 2588 | 0.190 |
Why?
| | Netherlands | 1 | 2021 | 84 | 0.180 |
Why?
| | Intelligence | 1 | 2022 | 113 | 0.170 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 679 | 0.170 |
Why?
| | Cognition Disorders | 2 | 2016 | 541 | 0.170 |
Why?
| | Chronic Pain | 2 | 2017 | 291 | 0.170 |
Why?
| | Neurodegenerative Diseases | 2 | 2025 | 142 | 0.170 |
Why?
| | Biological Variation, Population | 1 | 2020 | 21 | 0.160 |
Why?
| | Young Adult | 11 | 2025 | 14219 | 0.160 |
Why?
| | Human Development | 1 | 2020 | 20 | 0.160 |
Why?
| | Immune System | 1 | 2021 | 180 | 0.160 |
Why?
| | Risk Factors | 8 | 2022 | 10885 | 0.150 |
Why?
| | Marijuana Abuse | 2 | 2020 | 213 | 0.150 |
Why?
| | Genomic Imprinting | 1 | 2019 | 27 | 0.150 |
Why?
| | Comorbidity | 4 | 2017 | 1661 | 0.150 |
Why?
| | Mortality, Premature | 1 | 2019 | 15 | 0.150 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2018 | 36 | 0.140 |
Why?
| | Longevity | 1 | 2019 | 178 | 0.130 |
Why?
| | Anxiety Disorders | 1 | 2021 | 369 | 0.130 |
Why?
| | White Matter | 1 | 2020 | 153 | 0.130 |
Why?
| | Prevalence | 3 | 2021 | 2865 | 0.130 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 164 | 0.130 |
Why?
| | Self Report | 2 | 2022 | 870 | 0.130 |
Why?
| | International Classification of Diseases | 1 | 2018 | 150 | 0.130 |
Why?
| | Proteome | 1 | 2022 | 514 | 0.130 |
Why?
| | Mechanotransduction, Cellular | 1 | 2018 | 121 | 0.120 |
Why?
| | Middle Aged | 14 | 2025 | 36215 | 0.120 |
Why?
| | Angina Pectoris | 1 | 2017 | 76 | 0.120 |
Why?
| | Age Distribution | 1 | 2017 | 403 | 0.120 |
Why?
| | Aged, 80 and over | 5 | 2025 | 8333 | 0.120 |
Why?
| | Birth Order | 1 | 2016 | 14 | 0.120 |
Why?
| | Aged | 11 | 2025 | 26153 | 0.120 |
Why?
| | Gyrus Cinguli | 1 | 2016 | 97 | 0.120 |
Why?
| | Maternal Age | 1 | 2016 | 128 | 0.120 |
Why?
| | Apolipoprotein E4 | 1 | 2016 | 42 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 184 | 0.120 |
Why?
| | Genetic Markers | 1 | 2016 | 335 | 0.110 |
Why?
| | Facial Expression | 1 | 2016 | 75 | 0.110 |
Why?
| | Drug Prescriptions | 1 | 2017 | 288 | 0.110 |
Why?
| | Alcoholism | 2 | 2020 | 822 | 0.110 |
Why?
| | Transcriptome | 1 | 2021 | 1038 | 0.110 |
Why?
| | NF-kappa B | 1 | 2018 | 666 | 0.110 |
Why?
| | Neurodevelopmental Disorders | 1 | 2018 | 227 | 0.110 |
Why?
| | Synapses | 1 | 2018 | 439 | 0.100 |
Why?
| | Regression Analysis | 3 | 2011 | 1001 | 0.100 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 334 | 0.100 |
Why?
| | Pain | 1 | 2019 | 789 | 0.100 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2017 | 531 | 0.100 |
Why?
| | Databases, Factual | 2 | 2017 | 1490 | 0.100 |
Why?
| | Adolescent | 10 | 2025 | 22530 | 0.100 |
Why?
| | Chromosome Mapping | 2 | 2025 | 506 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1097 | 0.090 |
Why?
| | Logistic Models | 1 | 2017 | 2134 | 0.090 |
Why?
| | Incidence | 1 | 2019 | 2923 | 0.090 |
Why?
| | Alleles | 3 | 2022 | 894 | 0.090 |
Why?
| | Echo-Planar Imaging | 1 | 2011 | 24 | 0.080 |
Why?
| | Risk | 3 | 2020 | 919 | 0.080 |
Why?
| | Personality Inventory | 1 | 2011 | 134 | 0.080 |
Why?
| | Biomarkers | 2 | 2022 | 4295 | 0.080 |
Why?
| | Risk Assessment | 2 | 2018 | 3747 | 0.080 |
Why?
| | Organ Size | 2 | 2025 | 461 | 0.080 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 56 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2011 | 779 | 0.070 |
Why?
| | Alzheimer Disease | 1 | 2016 | 630 | 0.070 |
Why?
| | DiGeorge Syndrome | 1 | 2009 | 35 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3413 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2187 | 0.070 |
Why?
| | CpG Islands | 2 | 2019 | 163 | 0.070 |
Why?
| | Genotype | 3 | 2019 | 1852 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2010 | 344 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2022 | 11772 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1180 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2906 | 0.060 |
Why?
| | Reaction Time | 2 | 2018 | 433 | 0.060 |
Why?
| | Personal Protective Equipment | 1 | 2025 | 58 | 0.060 |
Why?
| | Sweden | 1 | 2025 | 115 | 0.060 |
Why?
| | Atrophy | 1 | 2025 | 199 | 0.050 |
Why?
| | Australia | 1 | 2025 | 288 | 0.050 |
Why?
| | Meta-Analysis as Topic | 2 | 2015 | 171 | 0.050 |
Why?
| | Canada | 1 | 2025 | 431 | 0.050 |
Why?
| | Genetic Association Studies | 2 | 2016 | 369 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2019 | 3623 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 5905 | 0.050 |
Why?
| | Life Change Events | 1 | 2024 | 146 | 0.050 |
Why?
| | Molecular Biology | 1 | 2022 | 58 | 0.040 |
Why?
| | Sulfurtransferases | 1 | 2021 | 10 | 0.040 |
Why?
| | Africa | 1 | 2021 | 119 | 0.040 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 109 | 0.040 |
Why?
| | Genome | 1 | 2022 | 305 | 0.040 |
Why?
| | Chromosomes, Human, X | 1 | 2019 | 77 | 0.040 |
Why?
| | Diffusion Tensor Imaging | 1 | 2020 | 75 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 467 | 0.040 |
Why?
| | Life Style | 1 | 2022 | 485 | 0.040 |
Why?
| | Chromosome Duplication | 1 | 2018 | 6 | 0.040 |
Why?
| | Systems Biology | 1 | 2019 | 69 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2018 | 44 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2019 | 291 | 0.030 |
Why?
| | F-Box Proteins | 1 | 2018 | 24 | 0.030 |
Why?
| | Death | 1 | 2019 | 132 | 0.030 |
Why?
| | Tobacco Use Disorder | 1 | 2020 | 217 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2018 | 119 | 0.030 |
Why?
| | Neural Pathways | 1 | 2019 | 313 | 0.030 |
Why?
| | Linear Models | 1 | 2019 | 845 | 0.030 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 231 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2020 | 473 | 0.030 |
Why?
| | Abnormalities, Multiple | 1 | 2018 | 199 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2018 | 179 | 0.030 |
Why?
| | Organoids | 1 | 2018 | 145 | 0.030 |
Why?
| | Research Design | 1 | 2023 | 1137 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2018 | 192 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 428 | 0.030 |
Why?
| | Denmark | 1 | 2016 | 51 | 0.030 |
Why?
| | Diseases in Twins | 1 | 2017 | 116 | 0.030 |
Why?
| | Mental Status and Dementia Tests | 1 | 2016 | 27 | 0.030 |
Why?
| | Cognitive Aging | 1 | 2016 | 19 | 0.030 |
Why?
| | Twins | 1 | 2017 | 152 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 273 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1547 | 0.030 |
Why?
| | Caudate Nucleus | 1 | 2015 | 22 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 1118 | 0.030 |
Why?
| | Prospective Studies | 2 | 2022 | 8057 | 0.030 |
Why?
| | Putamen | 1 | 2015 | 23 | 0.030 |
Why?
| | Gene Frequency | 1 | 2016 | 487 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 470 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 874 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 561 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2015 | 180 | 0.030 |
Why?
| | Stem Cells | 1 | 2018 | 628 | 0.030 |
Why?
| | Skull | 1 | 2015 | 162 | 0.020 |
Why?
| | Memory | 1 | 2016 | 295 | 0.020 |
Why?
| | Inheritance Patterns | 1 | 2013 | 45 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 583 | 0.020 |
Why?
| | Gene Expression | 1 | 2018 | 1476 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 66 | 0.020 |
Why?
| | Child | 3 | 2022 | 22707 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 65 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2018 | 740 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2014 | 462 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2507 | 0.020 |
Why?
| | Genome, Human | 1 | 2013 | 420 | 0.020 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2010 | 7 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 910 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 260 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2016 | 749 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2864 | 0.020 |
Why?
| | Neurons | 1 | 2018 | 1649 | 0.020 |
Why?
| | Hippocampus | 1 | 2015 | 971 | 0.020 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 429 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3342 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2015 | 1164 | 0.020 |
Why?
| | United States | 1 | 2025 | 16098 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4316 | 0.020 |
Why?
| | Hypertension | 1 | 2016 | 1273 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 5423 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2440 | 0.010 |
Why?
| | Signal Transduction | 1 | 2018 | 5216 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17291 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 6066 | 0.010 |
Why?
| | Pregnancy | 1 | 2016 | 7202 | 0.010 |
Why?
|
|
McIntosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|